Cytarabine Dose for Acute Myeloid Leukemia

B. Lowenberg; T. Pabst; E. Vellenga; W van Putten; H.C. Schouten; C. Graux; A Ferrant; P. Sonneveld; B.J. Biemond; A. Gratwohl; G.E. de Greef; L.F. Verdonck; M.R. Schaafsma; M. Gregor; M Theobald; U. Schanz; J. Maertens; G.J. Ossenkoppele

doi:10.1056/NEJMoa1010222

Cytarabine Dose for Acute Myeloid Leukemia

B. Lowenberg, T. Pabst, E. Vellenga, W van Putten, H.C. Schouten, C. Graux, A Ferrant, P. Sonneveld, B.J. Biemond, A. Gratwohl, G.E. de Greef, L.F. Verdonck, M.R. Schaafsma, M. Gregor, M Theobald, U. Schanz, J. Maertens, G.J. Ossenkoppele

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1027-1036
Journal	New England Journal of Medicine
Volume	364
Issue number	11
DOIs	https://doi.org/10.1056/NEJMoa1010222
Publication status	Published - 2011

Access to Document

10.1056/NEJMoa1010222

Cite this

Lowenberg, B., Pabst, T., Vellenga, E., van Putten, W., Schouten, H. C., Graux, C., Ferrant, A., Sonneveld, P., Biemond, B. J., Gratwohl, A., de Greef, G. E., Verdonck, L. F., Schaafsma, M. R., Gregor, M., Theobald, M., Schanz, U., Maertens, J., & Ossenkoppele, G. J. (2011). Cytarabine Dose for Acute Myeloid Leukemia. New England Journal of Medicine, 364(11), 1027-1036. https://doi.org/10.1056/NEJMoa1010222

@article{74cdb85156dd413390dcb37927109544,

title = "Cytarabine Dose for Acute Myeloid Leukemia",

author = "B. Lowenberg and T. Pabst and E. Vellenga and {van Putten}, W and H.C. Schouten and C. Graux and A Ferrant and P. Sonneveld and B.J. Biemond and A. Gratwohl and {de Greef}, G.E. and L.F. Verdonck and M.R. Schaafsma and M. Gregor and M Theobald and U. Schanz and J. Maertens and G.J. Ossenkoppele",

year = "2011",

doi = "10.1056/NEJMoa1010222",

language = "Undefined/Unknown",

volume = "364",

pages = "1027--1036",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "11",

}

Lowenberg, B, Pabst, T, Vellenga, E, van Putten, W, Schouten, HC, Graux, C, Ferrant, A, Sonneveld, P, Biemond, BJ, Gratwohl, A, de Greef, GE, Verdonck, LF, Schaafsma, MR, Gregor, M, Theobald, M, Schanz, U, Maertens, J & Ossenkoppele, GJ 2011, 'Cytarabine Dose for Acute Myeloid Leukemia', New England Journal of Medicine, vol. 364, no. 11, pp. 1027-1036. https://doi.org/10.1056/NEJMoa1010222

TY - JOUR

T1 - Cytarabine Dose for Acute Myeloid Leukemia

AU - Lowenberg, B.

AU - Pabst, T.

AU - Vellenga, E.

AU - van Putten, W

AU - Schouten, H.C.

AU - Graux, C.

AU - Ferrant, A

AU - Sonneveld, P.

AU - Biemond, B.J.

AU - Gratwohl, A.

AU - de Greef, G.E.

AU - Verdonck, L.F.

AU - Schaafsma, M.R.

AU - Gregor, M.

AU - Theobald, M

AU - Schanz, U.

AU - Maertens, J.

AU - Ossenkoppele, G.J.

PY - 2011

Y1 - 2011

U2 - 10.1056/NEJMoa1010222

DO - 10.1056/NEJMoa1010222

M3 - Article

C2 - 21410371

VL - 364

SP - 1027

EP - 1036

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 11

ER -